Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Latin American Multiple Myeloma Registry Study

NCT03955900 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03955900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Latin American Multiple Myeloma Registry Study
Lead sponsor
Janssen-Cilag Ltd.
Phase
Observational
Overall status
Completed
Start date
May 29, 2019
Completion date
June 30, 2022
Enrollment
2,059 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.